World News: 06:15 GMT Friday 23rd September 2016. [Novartis International AG via Thomson Reuters ONE via SPi World News] Novartis International AG / Novartis announces positive top-line results from ASCEND-4, a Phase III trial of Zykadia® in ... SPi World News, 4 weeks ago
Karolinska Development portfolio company Aprea Therapeutics updates clinical data from Phase Ib trial of APR-246 in ovarian cancer.
Efficacy and safety data for APR-246 in high grade serous ovarian cancer presented at ESMO 2016 annual meeting Details from the Aprea announcement follow: The Phase Ib clinical study included 28 patients, in a 3+3 dose escalation design of ...Forex TV, 1 week ago KAROLINSKA DEVELOPMENT : portfolio company Aprea Therapeutics updates clinical data from Phase Ib trial of APR-246 in ovarian cancer. 4 Traders, 1 week ago
Nearing 20-Month Mark, Sony's Tom Rothman Reviews Progress And Prospects At A Rapidly Changing Movie Studio
Nearly 20 months into his tenure as the chairman of Sony Pictures Entertainment's motion picture group, Thomas E. Rothman reckons he and his peers at the studio are about where Winston Churchill stood in November 1942, as the tides of World War II ...Mail.com, 2 weeks ago
Today Michael Gennaro, Goodspeed's Executive Director, announced the six sensational shows set for next season. Gennaro explained, "2017 is going to be an exciting year at Goodspeed. We're producing a classic musical comedy, bold new musicals, a ...Broadway World, 3 weeks ago
Genentech, a member of the Roche Group, has announced positive results for TECENTRIQ from the Phase III study, OAK. The study met its co-primary endpoints and showed a statistically significant and clinically meaningful improvement in overall ...Pharmaceutical Business Review, 1 month ago ROCHE : Phase III Study Showed Genentech's Cancer Immunotherapy TECENTRIQ (Atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy 4 Traders, 1 month ago Phase III Study Showed Genentech's Cancer Immunotherapy TECENTRIQ (Atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy Swiss Biotech, 1 month ago
on your WebpageAdd Widget >Get your members hooked!